nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—Abdominal pain upper—Vismodegib—skin cancer	0.0225	0.0225	CcSEcCtD
Tetrabenazine—Breast disorder—Vismodegib—skin cancer	0.0222	0.0222	CcSEcCtD
Tetrabenazine—Parkinsonism—Fluorouracil—skin cancer	0.0217	0.0217	CcSEcCtD
Tetrabenazine—Balance disorder—Fluorouracil—skin cancer	0.018	0.018	CcSEcCtD
Tetrabenazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.0142	0.0142	CcSEcCtD
Tetrabenazine—Memory impairment—Temozolomide—skin cancer	0.0136	0.0136	CcSEcCtD
Tetrabenazine—Menstruation irregular—Docetaxel—skin cancer	0.0129	0.0129	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.0125	0.0125	CcSEcCtD
Tetrabenazine—Irritability—Imiquimod—skin cancer	0.0124	0.0124	CcSEcCtD
Tetrabenazine—Nervous system disorder—Vismodegib—skin cancer	0.0119	0.0119	CcSEcCtD
Tetrabenazine—Skin disorder—Vismodegib—skin cancer	0.0117	0.0117	CcSEcCtD
Tetrabenazine—Breast disorder—Imiquimod—skin cancer	0.0117	0.0117	CcSEcCtD
Tetrabenazine—Gait disturbance—Temozolomide—skin cancer	0.011	0.011	CcSEcCtD
Tetrabenazine—Bronchitis—Imiquimod—skin cancer	0.0108	0.0108	CcSEcCtD
Tetrabenazine—Decreased appetite—Vismodegib—skin cancer	0.0105	0.0105	CcSEcCtD
Tetrabenazine—Dysuria—Imiquimod—skin cancer	0.0105	0.0105	CcSEcCtD
Tetrabenazine—Fatigue—Vismodegib—skin cancer	0.0104	0.0104	CcSEcCtD
Tetrabenazine—Dysarthria—Fluorouracil—skin cancer	0.0104	0.0104	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Imiquimod—skin cancer	0.0104	0.0104	CcSEcCtD
Tetrabenazine—Constipation—Vismodegib—skin cancer	0.0103	0.0103	CcSEcCtD
Tetrabenazine—Disorientation—Bleomycin—skin cancer	0.0103	0.0103	CcSEcCtD
Tetrabenazine—Depression—Imiquimod—skin cancer	0.00996	0.00996	CcSEcCtD
Tetrabenazine—Eye disorder—Vemurafenib—skin cancer	0.00983	0.00983	CcSEcCtD
Tetrabenazine—Cardiac disorder—Vemurafenib—skin cancer	0.00976	0.00976	CcSEcCtD
Tetrabenazine—Angiopathy—Vemurafenib—skin cancer	0.00954	0.00954	CcSEcCtD
Tetrabenazine—Photophobia—Fluorouracil—skin cancer	0.00926	0.00926	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Imiquimod—skin cancer	0.00885	0.00885	CcSEcCtD
Tetrabenazine—Urethral disorder—Imiquimod—skin cancer	0.00879	0.00879	CcSEcCtD
Tetrabenazine—Asthenia—Vismodegib—skin cancer	0.00867	0.00867	CcSEcCtD
Tetrabenazine—Eye disorder—Imiquimod—skin cancer	0.00838	0.00838	CcSEcCtD
Tetrabenazine—Diarrhoea—Vismodegib—skin cancer	0.00827	0.00827	CcSEcCtD
Tetrabenazine—Angiopathy—Imiquimod—skin cancer	0.00814	0.00814	CcSEcCtD
Tetrabenazine—Disorientation—Fluorouracil—skin cancer	0.008	0.008	CcSEcCtD
Tetrabenazine—Mental disorder—Imiquimod—skin cancer	0.00786	0.00786	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00774	0.00774	CcSEcCtD
Tetrabenazine—Vomiting—Vismodegib—skin cancer	0.00769	0.00769	CcSEcCtD
Tetrabenazine—Dysphagia—Dactinomycin—skin cancer	0.00742	0.00742	CcSEcCtD
Tetrabenazine—Nervous system disorder—Vemurafenib—skin cancer	0.00733	0.00733	CcSEcCtD
Tetrabenazine—Ataxia—Temozolomide—skin cancer	0.0073	0.0073	CcSEcCtD
Tetrabenazine—Skin disorder—Vemurafenib—skin cancer	0.00726	0.00726	CcSEcCtD
Tetrabenazine—Nausea—Vismodegib—skin cancer	0.00718	0.00718	CcSEcCtD
Tetrabenazine—Agitation—Imiquimod—skin cancer	0.00717	0.00717	CcSEcCtD
Tetrabenazine—Osteoarthritis—Fluorouracil—skin cancer	0.00716	0.00716	CcSEcCtD
Tetrabenazine—Breast disorder—Temozolomide—skin cancer	0.00702	0.00702	CcSEcCtD
Tetrabenazine—Hypotension—Vemurafenib—skin cancer	0.00698	0.00698	CcSEcCtD
Tetrabenazine—Irritability—Fluorouracil—skin cancer	0.00683	0.00683	CcSEcCtD
Tetrabenazine—Ataxia—Fluorouracil—skin cancer	0.00673	0.00673	CcSEcCtD
Tetrabenazine—Dysphagia—Temozolomide—skin cancer	0.00671	0.00671	CcSEcCtD
Tetrabenazine—Anxiety—Imiquimod—skin cancer	0.00662	0.00662	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.0066	0.0066	CcSEcCtD
Tetrabenazine—Dry mouth—Imiquimod—skin cancer	0.0065	0.0065	CcSEcCtD
Tetrabenazine—Decreased appetite—Vemurafenib—skin cancer	0.00649	0.00649	CcSEcCtD
Tetrabenazine—Bronchitis—Temozolomide—skin cancer	0.00646	0.00646	CcSEcCtD
Tetrabenazine—Fatigue—Vemurafenib—skin cancer	0.00644	0.00644	CcSEcCtD
Tetrabenazine—Constipation—Vemurafenib—skin cancer	0.00639	0.00639	CcSEcCtD
Tetrabenazine—Dysuria—Temozolomide—skin cancer	0.00628	0.00628	CcSEcCtD
Tetrabenazine—Nervous system disorder—Imiquimod—skin cancer	0.00625	0.00625	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00624	0.00624	CcSEcCtD
Tetrabenazine—Skin disorder—Imiquimod—skin cancer	0.00619	0.00619	CcSEcCtD
Tetrabenazine—Dysphagia—Fluorouracil—skin cancer	0.00619	0.00619	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Imiquimod—skin cancer	0.00616	0.00616	CcSEcCtD
Tetrabenazine—Depression—Temozolomide—skin cancer	0.00597	0.00597	CcSEcCtD
Tetrabenazine—Body temperature increased—Vemurafenib—skin cancer	0.0059	0.0059	CcSEcCtD
Tetrabenazine—Insomnia—Imiquimod—skin cancer	0.00576	0.00576	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00575	0.00575	CcSEcCtD
Tetrabenazine—Dyspnoea—Imiquimod—skin cancer	0.00568	0.00568	CcSEcCtD
Tetrabenazine—Somnolence—Imiquimod—skin cancer	0.00566	0.00566	CcSEcCtD
Tetrabenazine—Decreased appetite—Imiquimod—skin cancer	0.00554	0.00554	CcSEcCtD
Tetrabenazine—Fatigue—Imiquimod—skin cancer	0.00549	0.00549	CcSEcCtD
Tetrabenazine—Asthenia—Vemurafenib—skin cancer	0.00536	0.00536	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Temozolomide—skin cancer	0.00531	0.00531	CcSEcCtD
Tetrabenazine—Urethral disorder—Temozolomide—skin cancer	0.00527	0.00527	CcSEcCtD
Tetrabenazine—Feeling abnormal—Imiquimod—skin cancer	0.00525	0.00525	CcSEcCtD
Tetrabenazine—Diarrhoea—Vemurafenib—skin cancer	0.00511	0.00511	CcSEcCtD
Tetrabenazine—Body temperature increased—Imiquimod—skin cancer	0.00504	0.00504	CcSEcCtD
Tetrabenazine—Eye disorder—Temozolomide—skin cancer	0.00502	0.00502	CcSEcCtD
Tetrabenazine—Cardiac disorder—Temozolomide—skin cancer	0.00499	0.00499	CcSEcCtD
Tetrabenazine—Leukopenia—Bleomycin—skin cancer	0.00496	0.00496	CcSEcCtD
Tetrabenazine—Dizziness—Vemurafenib—skin cancer	0.00494	0.00494	CcSEcCtD
Tetrabenazine—Angiopathy—Temozolomide—skin cancer	0.00488	0.00488	CcSEcCtD
Tetrabenazine—Ataxia—Docetaxel—skin cancer	0.00486	0.00486	CcSEcCtD
Tetrabenazine—Vomiting—Vemurafenib—skin cancer	0.00475	0.00475	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Docetaxel—skin cancer	0.00472	0.00472	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Docetaxel—skin cancer	0.00472	0.00472	CcSEcCtD
Tetrabenazine—Mental disorder—Temozolomide—skin cancer	0.00471	0.00471	CcSEcCtD
Tetrabenazine—Headache—Vemurafenib—skin cancer	0.00468	0.00468	CcSEcCtD
Tetrabenazine—Breast disorder—Docetaxel—skin cancer	0.00467	0.00467	CcSEcCtD
Tetrabenazine—Leukopenia—Dactinomycin—skin cancer	0.00463	0.00463	CcSEcCtD
Tetrabenazine—Asthenia—Imiquimod—skin cancer	0.00457	0.00457	CcSEcCtD
Tetrabenazine—Confusional state—Bleomycin—skin cancer	0.00456	0.00456	CcSEcCtD
Tetrabenazine—Dysphagia—Docetaxel—skin cancer	0.00446	0.00446	CcSEcCtD
Tetrabenazine—Nausea—Vemurafenib—skin cancer	0.00444	0.00444	CcSEcCtD
Tetrabenazine—Tremor—Temozolomide—skin cancer	0.00438	0.00438	CcSEcCtD
Tetrabenazine—Diarrhoea—Imiquimod—skin cancer	0.00436	0.00436	CcSEcCtD
Tetrabenazine—Agitation—Temozolomide—skin cancer	0.0043	0.0043	CcSEcCtD
Tetrabenazine—Hypotension—Bleomycin—skin cancer	0.00423	0.00423	CcSEcCtD
Tetrabenazine—Dizziness—Imiquimod—skin cancer	0.00421	0.00421	CcSEcCtD
Tetrabenazine—Leukopenia—Temozolomide—skin cancer	0.00419	0.00419	CcSEcCtD
Tetrabenazine—Vomiting—Imiquimod—skin cancer	0.00405	0.00405	CcSEcCtD
Tetrabenazine—Dyspnoea—Bleomycin—skin cancer	0.00403	0.00403	CcSEcCtD
Tetrabenazine—Headache—Imiquimod—skin cancer	0.00399	0.00399	CcSEcCtD
Tetrabenazine—Anxiety—Temozolomide—skin cancer	0.00397	0.00397	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00395	0.00395	CcSEcCtD
Tetrabenazine—Decreased appetite—Bleomycin—skin cancer	0.00393	0.00393	CcSEcCtD
Tetrabenazine—Dry mouth—Temozolomide—skin cancer	0.00389	0.00389	CcSEcCtD
Tetrabenazine—Leukopenia—Fluorouracil—skin cancer	0.00386	0.00386	CcSEcCtD
Tetrabenazine—Confusional state—Temozolomide—skin cancer	0.00385	0.00385	CcSEcCtD
Tetrabenazine—Nausea—Imiquimod—skin cancer	0.00378	0.00378	CcSEcCtD
Tetrabenazine—Nervous system disorder—Temozolomide—skin cancer	0.00374	0.00374	CcSEcCtD
Tetrabenazine—Feeling abnormal—Bleomycin—skin cancer	0.00373	0.00373	CcSEcCtD
Tetrabenazine—Skin disorder—Temozolomide—skin cancer	0.00371	0.00371	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Temozolomide—skin cancer	0.00369	0.00369	CcSEcCtD
Tetrabenazine—Decreased appetite—Dactinomycin—skin cancer	0.00367	0.00367	CcSEcCtD
Tetrabenazine—Fatigue—Dactinomycin—skin cancer	0.00364	0.00364	CcSEcCtD
Tetrabenazine—Body temperature increased—Bleomycin—skin cancer	0.00358	0.00358	CcSEcCtD
Tetrabenazine—Confusional state—Fluorouracil—skin cancer	0.00355	0.00355	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Docetaxel—skin cancer	0.00353	0.00353	CcSEcCtD
Tetrabenazine—Urethral disorder—Docetaxel—skin cancer	0.0035	0.0035	CcSEcCtD
Tetrabenazine—Feeling abnormal—Dactinomycin—skin cancer	0.00348	0.00348	CcSEcCtD
Tetrabenazine—Insomnia—Temozolomide—skin cancer	0.00345	0.00345	CcSEcCtD
Tetrabenazine—Nervous system disorder—Fluorouracil—skin cancer	0.00345	0.00345	CcSEcCtD
Tetrabenazine—Dyspnoea—Temozolomide—skin cancer	0.0034	0.0034	CcSEcCtD
Tetrabenazine—Somnolence—Temozolomide—skin cancer	0.00339	0.00339	CcSEcCtD
Tetrabenazine—Eye disorder—Docetaxel—skin cancer	0.00334	0.00334	CcSEcCtD
Tetrabenazine—Body temperature increased—Dactinomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Tetrabenazine—Decreased appetite—Temozolomide—skin cancer	0.00332	0.00332	CcSEcCtD
Tetrabenazine—Cardiac disorder—Docetaxel—skin cancer	0.00332	0.00332	CcSEcCtD
Tetrabenazine—Fatigue—Temozolomide—skin cancer	0.00329	0.00329	CcSEcCtD
Tetrabenazine—Hypotension—Fluorouracil—skin cancer	0.00329	0.00329	CcSEcCtD
Tetrabenazine—Constipation—Temozolomide—skin cancer	0.00326	0.00326	CcSEcCtD
Tetrabenazine—Asthenia—Bleomycin—skin cancer	0.00325	0.00325	CcSEcCtD
Tetrabenazine—Angiopathy—Docetaxel—skin cancer	0.00324	0.00324	CcSEcCtD
Tetrabenazine—Insomnia—Fluorouracil—skin cancer	0.00318	0.00318	CcSEcCtD
Tetrabenazine—Feeling abnormal—Temozolomide—skin cancer	0.00315	0.00315	CcSEcCtD
Tetrabenazine—Dyspnoea—Fluorouracil—skin cancer	0.00314	0.00314	CcSEcCtD
Tetrabenazine—Mental disorder—Docetaxel—skin cancer	0.00313	0.00313	CcSEcCtD
Tetrabenazine—Somnolence—Fluorouracil—skin cancer	0.00313	0.00313	CcSEcCtD
Tetrabenazine—Decreased appetite—Fluorouracil—skin cancer	0.00306	0.00306	CcSEcCtD
Tetrabenazine—Asthenia—Dactinomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Tetrabenazine—Body temperature increased—Temozolomide—skin cancer	0.00302	0.00302	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fluorouracil—skin cancer	0.0029	0.0029	CcSEcCtD
Tetrabenazine—Diarrhoea—Dactinomycin—skin cancer	0.00289	0.00289	CcSEcCtD
Tetrabenazine—Vomiting—Bleomycin—skin cancer	0.00288	0.00288	CcSEcCtD
Tetrabenazine—Leukopenia—Docetaxel—skin cancer	0.00278	0.00278	CcSEcCtD
Tetrabenazine—Body temperature increased—Fluorouracil—skin cancer	0.00278	0.00278	CcSEcCtD
Tetrabenazine—Asthenia—Temozolomide—skin cancer	0.00274	0.00274	CcSEcCtD
Tetrabenazine—Nausea—Bleomycin—skin cancer	0.00269	0.00269	CcSEcCtD
Tetrabenazine—Vomiting—Dactinomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00263	0.00263	CcSEcCtD
Tetrabenazine—Diarrhoea—Temozolomide—skin cancer	0.00261	0.00261	CcSEcCtD
Tetrabenazine—Dry mouth—Docetaxel—skin cancer	0.00259	0.00259	CcSEcCtD
Tetrabenazine—Confusional state—Docetaxel—skin cancer	0.00256	0.00256	CcSEcCtD
Tetrabenazine—Dizziness—Temozolomide—skin cancer	0.00252	0.00252	CcSEcCtD
Tetrabenazine—Nausea—Dactinomycin—skin cancer	0.00251	0.00251	CcSEcCtD
Tetrabenazine—Nervous system disorder—Docetaxel—skin cancer	0.00249	0.00249	CcSEcCtD
Tetrabenazine—Skin disorder—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Tetrabenazine—Vomiting—Temozolomide—skin cancer	0.00243	0.00243	CcSEcCtD
Tetrabenazine—Diarrhoea—Fluorouracil—skin cancer	0.00241	0.00241	CcSEcCtD
Tetrabenazine—Headache—Temozolomide—skin cancer	0.00239	0.00239	CcSEcCtD
Tetrabenazine—Hypotension—Docetaxel—skin cancer	0.00237	0.00237	CcSEcCtD
Tetrabenazine—Dizziness—Fluorouracil—skin cancer	0.00233	0.00233	CcSEcCtD
Tetrabenazine—Insomnia—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Tetrabenazine—Nausea—Temozolomide—skin cancer	0.00227	0.00227	CcSEcCtD
Tetrabenazine—Dyspnoea—Docetaxel—skin cancer	0.00226	0.00226	CcSEcCtD
Tetrabenazine—Somnolence—Docetaxel—skin cancer	0.00226	0.00226	CcSEcCtD
Tetrabenazine—Vomiting—Fluorouracil—skin cancer	0.00224	0.00224	CcSEcCtD
Tetrabenazine—Decreased appetite—Docetaxel—skin cancer	0.00221	0.00221	CcSEcCtD
Tetrabenazine—Headache—Fluorouracil—skin cancer	0.0022	0.0022	CcSEcCtD
Tetrabenazine—Fatigue—Docetaxel—skin cancer	0.00219	0.00219	CcSEcCtD
Tetrabenazine—Constipation—Docetaxel—skin cancer	0.00217	0.00217	CcSEcCtD
Tetrabenazine—Feeling abnormal—Docetaxel—skin cancer	0.00209	0.00209	CcSEcCtD
Tetrabenazine—Nausea—Fluorouracil—skin cancer	0.00209	0.00209	CcSEcCtD
Tetrabenazine—Body temperature increased—Docetaxel—skin cancer	0.00201	0.00201	CcSEcCtD
Tetrabenazine—Asthenia—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Tetrabenazine—Diarrhoea—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Tetrabenazine—Dizziness—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Tetrabenazine—Vomiting—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Tetrabenazine—Headache—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Tetrabenazine—Nausea—Docetaxel—skin cancer	0.00151	0.00151	CcSEcCtD
